Emel Öztürk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emel Öztürk has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ali Tuğrul Akin
Istinye Universitesi
9 shared publications - Derya Karabulut
Department of Histology-Embryology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
8 shared publications - Emin Kaymak
Department of Histology and Embryology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey
8 shared publications - Birkan Yakan
Erciyes Universitesi
6 shared publications - Nurhan Kuloğlu
Niğde Ömer Halisdemir Üniversitesi
4 shared publications - Betül Yalçın
Department of Histology and Embryology, Faculty of Medicine, Adıyaman University, Adıyaman, Turkey
2 shared publications
Latest Publications
- 15 June 2026
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 16 (2) , 215-223
Sisplatin kaynaklı hepatotoksisitede Rapamisin ve 3-Metiladenin'in Isı şoku proteinleri üzerindeki etkisi
Amaç: Bu çalışmanın amacı, otofaji aktivatörü (rapamisin) ve otofaji inhibitörünün (3-metiladenin) sisplatin kaynaklı hepatotoksisitede ısı şoku proteinleri (HSP) üzerindeki etkilerini araştırmaktı.Gereç ve Yöntem: Çalışmadaki Wistar albino sıçanları (28) dört eşit gruba ayrıldı. Kontrol grubu, Sisplatin grubu; Deneyin 7. gününde, tek doz 8 mg/kg intraperitoneal (ip) sisplatin uygulandı, Rapamisin+Sisplatin (Rapamisin grubu); Deneyin 1. gününden itibaren, rapamisin 2 mg/kg(ip) günde bir kez 15 gün boyunca uygulandı, 8 mg/kg(ip) tek doz sisplatin 7. günde uygulandı, 3-metiladenin+Sisplatin (3-Metiladenin grubu) 15 mg/kg(ip) günde bir kez 15 gün boyunca uygulandı, 8 mg/kg(ip) tek doz sisplatin 7. günde uygulandı. Karaciğer dokuları için rutin histolojik teknikler uygulandı. HSP'leri tanımlamak için immünohistokimya boyama yapıldı. Apoptozu göstermek için TUNEL yapıldı.Bulgular: Sisplatin grubundaki tüm HSP'ler kontrole kıyasla istatistiksel olarak arttı. Rapamisin, cis tarafından artırılan tüm HSP'lerin ekspresyonunun azalmasına neden oldu. 3-Metiladenin, Rapamisin ile karşılaştırıldığında HSP'lerde daha az etkiliydi. TUNEL pozitif hücreler Cisplatin grubunda istatistiksel olarak arttı. Rapamisin kontrol grubuna benzerdi. TUNEL pozitif hücreler 3-metiladenin grubunda değişmedi.Sonuç: Rapamisin'in dokuda Cisplatin kaynaklı oksidatif stresin azaltılmasına katkıda bulunarak hem HSP'leri hem de ilgili hücre ölümünü azalttığını düşünüyoruz. Dokuda 3-Metiladenin ile otofaji inhibisyonu Cisplatin kaynaklı HSP'lerin ekspresyonunun artmasına neden olur. Sonuç olarak Rapamisin, Cisplatin toksisitesinde HSP'ler üzerinde 3-Metiladenin'den daha etkilidir.
- 15 June 2026
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 16 (2) , 215-223
Sisplatin kaynaklı hepatotoksisitede Rapamisin ve 3-Metiladenin'in Isı şoku proteinleri üzerindeki etkisi
Amaç: Bu çalışmanın amacı, otofaji aktivatörü (rapamisin) ve otofaji inhibitörünün (3-metiladenin) sisplatin kaynaklı hepatotoksisitede ısı şoku proteinleri (HSP) üzerindeki etkilerini araştırmaktı.Gereç ve Yöntem: Çalışmadaki Wistar albino sıçanları (28) dört eşit gruba ayrıldı. Kontrol grubu, Sisplatin grubu; Deneyin 7. gününde, tek doz 8 mg/kg intraperitoneal (ip) sisplatin uygulandı, Rapamisin+Sisplatin (Rapamisin grubu); Deneyin 1. gününden itibaren, rapamisin 2 mg/kg(ip) günde bir kez 15 gün boyunca uygulandı, 8 mg/kg(ip) tek doz sisplatin 7. günde uygulandı, 3-metiladenin+Sisplatin (3-Metiladenin grubu) 15 mg/kg(ip) günde bir kez 15 gün boyunca uygulandı, 8 mg/kg(ip) tek doz sisplatin 7. günde uygulandı. Karaciğer dokuları için rutin histolojik teknikler uygulandı. HSP'leri tanımlamak için immünohistokimya boyama yapıldı. Apoptozu göstermek için TUNEL yapıldı.Bulgular: Sisplatin grubundaki tüm HSP'ler kontrole kıyasla istatistiksel olarak arttı. Rapamisin, cis tarafından artırılan tüm HSP'lerin ekspresyonunun azalmasına neden oldu. 3-Metiladenin, Rapamisin ile karşılaştırıldığında HSP'lerde daha az etkiliydi. TUNEL pozitif hücreler Cisplatin grubunda istatistiksel olarak arttı. Rapamisin kontrol grubuna benzerdi. TUNEL pozitif hücreler 3-metiladenin grubunda değişmedi.Sonuç: Rapamisin'in dokuda Cisplatin kaynaklı oksidatif stresin azaltılmasına katkıda bulunarak hem HSP'leri hem de ilgili hücre ölümünü azalttığını düşünüyoruz. Dokuda 3-Metiladenin ile otofaji inhibisyonu Cisplatin kaynaklı HSP'lerin ekspresyonunun artmasına neden olur. Sonuç olarak Rapamisin, Cisplatin toksisitesinde HSP'ler üzerinde 3-Metiladenin'den daha etkilidir.
- Open Access
- 19 July 2024
- Published by Springer Nature in Research Square
Flavopiridol Suppresses Cell Proliferation and Metastasis and Induces Endoplasmic Reticulum Stress of Triple Negative Breast Cancer Cells
Background As the number of breast cancer, which is the most common type of cancer, increases, alternative medicine has come to the fore. In this study, it was aimed to investigate the effect of flavopiridol on cell viability and apoptotic pathways associated with endoplasmic reticulum stress (ERS) on triple negative breast cancer cells. Methods In this study, cell viability test (MTS) was used for the effect of flavopiridol on the viability of triple negative breast cancer cells and clonogenic assay to determine its effect on colony formation. Migration assay showed migration rates of cells, expressions of proteins involved in apoptosis, ERS [Glucose regulated protein (GRP78), DNA damage inducible gene 153 (GADD153) and the apoptotic rate was measured with Annexin V. Results Flavopiridol was found to significantly reduce cell viability in the triple negative breast cancer cell lines in the 200nM-700nM dose range. We also found that FP induces apoptosis via ERS. Conclusion Our results showed that flavopiridol, when used in combination with other cytotoxic chemotherapeutic agents, will have promising potential for the treatment of patients with aggressive breast cancer, but further studies are needed in this regard.
- 19 July 2024
- Published by Springer Nature in Research Square
Open AccessFlavopiridol Suppresses Cell Proliferation and Metastasis and Induces Endoplasmic Reticulum Stress of Triple Negative Breast Cancer Cells
Background As the number of breast cancer, which is the most common type of cancer, increases, alternative medicine has come to the fore. In this study, it was aimed to investigate the effect of flavopiridol on cell viability and apoptotic pathways associated with endoplasmic reticulum stress (ERS) on triple negative breast cancer cells. Methods In this study, cell viability test (MTS) was used for the effect of flavopiridol on the viability of triple negative breast cancer cells and clonogenic assay to determine its effect on colony formation. Migration assay showed migration rates of cells, expressions of proteins involved in apoptosis, ERS [Glucose regulated protein (GRP78), DNA damage inducible gene 153 (GADD153) and the apoptotic rate was measured with Annexin V. Results Flavopiridol was found to significantly reduce cell viability in the triple negative breast cancer cell lines in the 200nM-700nM dose range. We also found that FP induces apoptosis via ERS. Conclusion Our results showed that flavopiridol, when used in combination with other cytotoxic chemotherapeutic agents, will have promising potential for the treatment of patients with aggressive breast cancer, but further studies are needed in this regard.
- Open Access
- 8 July 2023
- Published by National Documentation Centre (EKT) in Journal of the Hellenic Veterinary Medical Society
- Vol. 74 (2) , 5569-5576
Thymoquinone attenuates doxorubicin-induced lung damage via heat shock proteins, inflammation and endoplasmic reticulum stress
The aim of this study is to determine possible therapeutic effects of THQ on doxorubicin induced lung damage in rats. Rats were divided into five groups (n = 8): control, THQ, olive oil, DOX (a single dose of 15 mg/kg intraperitoneally (i.p.) on seventh day of the experiment), and DOX+THQ (10 mg/kg THQ per day and 15 mg/kg DOX i.p. on seventh day). Animals were euthanized, and lung tissues were evaluated histopathologically. Caspase3, GRP78, GADD153, HSP90, HSP70, PCNA, COX2 and TNFα immunostaining were performed to determine the expression levels of these proteins among groups. TUNEL method was used for evaluation of apoptotic index. Moreover, total antioxidant status (TAS), total oxidant status (TOS) and IL6 in lung tissue were measured by ELISA assay. The DOX group had histopathological deterioration compared to the control group. There was an increase in apoptotic index, caspase 3, GRP78, GADD153, HSP90, HSP70, PCNA, COX2 and TNFα expressions in the DOX group. While TAS level of the DOX group decreased, IL6 and TOS level increased when compared with the other groups. However, there was improvement in lung tissue in DOX + THQ group compared to the DOX group. There was a decrease in apoptotic index, caspase 3, GRP78, GADD153, HSP90, HSP70, PCNA, COX2, TNFα expressions and TOS, IL6 in DOX+THQ group compared to the DOX group. We suggest that THQ can be used as a protective agent to reduce the toxic effects of DOX.
- 8 July 2023
- Published by National Documentation Centre (EKT) in Journal of the Hellenic Veterinary Medical Society
- Vol. 74 (2) , 5569-5576
Open AccessThymoquinone attenuates doxorubicin-induced lung damage via heat shock proteins, inflammation and endoplasmic reticulum stress
The aim of this study is to determine possible therapeutic effects of THQ on doxorubicin induced lung damage in rats. Rats were divided into five groups (n = 8): control, THQ, olive oil, DOX (a single dose of 15 mg/kg intraperitoneally (i.p.) on seventh day of the experiment), and DOX+THQ (10 mg/kg THQ per day and 15 mg/kg DOX i.p. on seventh day). Animals were euthanized, and lung tissues were evaluated histopathologically. Caspase3, GRP78, GADD153, HSP90, HSP70, PCNA, COX2 and TNFα immunostaining were performed to determine the expression levels of these proteins among groups. TUNEL method was used for evaluation of apoptotic index. Moreover, total antioxidant status (TAS), total oxidant status (TOS) and IL6 in lung tissue were measured by ELISA assay. The DOX group had histopathological deterioration compared to the control group. There was an increase in apoptotic index, caspase 3, GRP78, GADD153, HSP90, HSP70, PCNA, COX2 and TNFα expressions in the DOX group. While TAS level of the DOX group decreased, IL6 and TOS level increased when compared with the other groups. However, there was improvement in lung tissue in DOX + THQ group compared to the DOX group. There was a decrease in apoptotic index, caspase 3, GRP78, GADD153, HSP90, HSP70, PCNA, COX2, TNFα expressions and TOS, IL6 in DOX+THQ group compared to the DOX group. We suggest that THQ can be used as a protective agent to reduce the toxic effects of DOX.
- 31 January 2023
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 7 (1) , 529-536
Histopathological Changes In Lung Tissue Caused By Diabetes: A Review
Diabetes mellitus associated with oxidative stress and inflammation can affect many organs. While the effects of diabetes on many organs are well known and documented, its mechanisms of action on the lung are known far less. Hyperglycemia can lead to lung damage by increasing oxidative stresses and inflammation. Diabetes may be a trigger for pulmonary fibrosis, as studies suggest that there may be an important link between pulmonary fibrosis and diabetes. In this review, the histopathological changes caused by diabetes in the lung tissue were summarized. In addition, changes in the lung due to inflammation, oxidative stress and pulmonary fibrosis mechanisms were evaluated.
- 31 January 2023
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 7 (1) , 529-536
Histopathological Changes In Lung Tissue Caused By Diabetes: A Review
Diabetes mellitus associated with oxidative stress and inflammation can affect many organs. While the effects of diabetes on many organs are well known and documented, its mechanisms of action on the lung are known far less. Hyperglycemia can lead to lung damage by increasing oxidative stresses and inflammation. Diabetes may be a trigger for pulmonary fibrosis, as studies suggest that there may be an important link between pulmonary fibrosis and diabetes. In this review, the histopathological changes caused by diabetes in the lung tissue were summarized. In addition, changes in the lung due to inflammation, oxidative stress and pulmonary fibrosis mechanisms were evaluated.
- 25 March 2022
- Published by Academician Publishing
Güncel Fizyoloji-Histoloji-Embriyoloji Çalışmaları III
Akademisyen Yayınevi yöneticileri, yaklaşık 30 yıllık yayın tecrübesini, kendi tüzel kişiliklerine aktararak uzun zamandan beri, ticarî faaliyetlerini sürdürmektedir. Anılan süre içinde, başta sağlık ve sosyal bilimler, kültürel ve sanatsal konular dahil 2000 kitabı yayımlamanın gururu içindedir. Uluslararası yayınevi olmanın alt yapısını tamamlayan Akademisyen, Türkçe ve yabancı dillerde yayın yapmanın yanında, küresel bir marka yaratmanın peşindedir.Bilimsel ve düşünsel çalışmaların kalıcı belgeleri sayılan kitaplar, bilgi kayıt ortamı olarak yüzlerce yılın tanıklarıdır. Matbaanın icadıyla varoluşunu sağlam temellere oturtan kitabın geleceği, her ne kadar yeni buluşların yörüngesine taşınmış olsa da, daha uzun süre hayatımızda yer edineceği muhakkaktır.
- 25 March 2022
- Published by Academician Publishing
Güncel Fizyoloji-Histoloji-Embriyoloji Çalışmaları III
Akademisyen Yayınevi yöneticileri, yaklaşık 30 yıllık yayın tecrübesini, kendi tüzel kişiliklerine aktararak uzun zamandan beri, ticarî faaliyetlerini sürdürmektedir. Anılan süre içinde, başta sağlık ve sosyal bilimler, kültürel ve sanatsal konular dahil 2000 kitabı yayımlamanın gururu içindedir. Uluslararası yayınevi olmanın alt yapısını tamamlayan Akademisyen, Türkçe ve yabancı dillerde yayın yapmanın yanında, küresel bir marka yaratmanın peşindedir.Bilimsel ve düşünsel çalışmaların kalıcı belgeleri sayılan kitaplar, bilgi kayıt ortamı olarak yüzlerce yılın tanıklarıdır. Matbaanın icadıyla varoluşunu sağlam temellere oturtan kitabın geleceği, her ne kadar yeni buluşların yörüngesine taşınmış olsa da, daha uzun süre hayatımızda yer edineceği muhakkaktır.
- 16 October 2021
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 53 (1) , 133-143
Evaluation by different mechanisms of the protective effects of vitamin B12 on methotrexate nephrotoxicity
Methotrexate is used for cure of many cancer types. It has many side effects. For this reason, obtaining a nephroprotective agent is obligatory. In the study, our aim is to determine probable effects of Vitamin B12 on MTX caused kidney damages in rats. Rats were randomly divided into 4 groups, including 8 animals in each group. Control group, VitB12 group (3 μg-kg-ip B12 throughout 15 days), MTX group (at the 8th day of experiment, a single dose of 20 mg-kg-ip MTX), Vit B12 + MTX group (3 μg-kg-ip B12 throughout 15 days and at the 8th day of experiment, a single dose of 20 mg-kg-ip MTX) Animals were anesthetized and kidney tissues were removed to evaluate biochemically, immunohistochemically and histopathologycally. There were histopathological deteriorations, rises of apoptotic cells, expressions of heat shock proteins, endoplasmic reticulum stress and inflammation markers in the MTX group. In the MTX group, Superoxide Dismutase (SOD), Total Antioxidant Status (TAS) and Catalase (CAT) levels decreased, but Total Oxidant Status TOS, Malondialdehyde (MDA) and interleukin-6 (IL6) levels increased. In addition, there was amelioration in kidney tissue in Vit B12 + MTX group compared to the MTX group. We suggest that Vit B12 can be used to reduce the toxic effects of MTX.
- 16 October 2021
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 53 (1) , 133-143
Evaluation by different mechanisms of the protective effects of vitamin B12 on methotrexate nephrotoxicity
Methotrexate is used for cure of many cancer types. It has many side effects. For this reason, obtaining a nephroprotective agent is obligatory. In the study, our aim is to determine probable effects of Vitamin B12 on MTX caused kidney damages in rats. Rats were randomly divided into 4 groups, including 8 animals in each group. Control group, VitB12 group (3 μg-kg-ip B12 throughout 15 days), MTX group (at the 8th day of experiment, a single dose of 20 mg-kg-ip MTX), Vit B12 + MTX group (3 μg-kg-ip B12 throughout 15 days and at the 8th day of experiment, a single dose of 20 mg-kg-ip MTX) Animals were anesthetized and kidney tissues were removed to evaluate biochemically, immunohistochemically and histopathologycally. There were histopathological deteriorations, rises of apoptotic cells, expressions of heat shock proteins, endoplasmic reticulum stress and inflammation markers in the MTX group. In the MTX group, Superoxide Dismutase (SOD), Total Antioxidant Status (TAS) and Catalase (CAT) levels decreased, but Total Oxidant Status TOS, Malondialdehyde (MDA) and interleukin-6 (IL6) levels increased. In addition, there was amelioration in kidney tissue in Vit B12 + MTX group compared to the MTX group. We suggest that Vit B12 can be used to reduce the toxic effects of MTX.
- Open Access
- 30 September 2021
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 46 (3) , 1184-1190
Histological evaluation of the effects of rapamycin and 3-methyladenine on cisplatin-induced epididymal injury in rats
Purpose: In this study, we aimed to determine the effects of autophagy inhibitor and activator on Cisplatin (Cis)-induced tissue damage. Materials and Methods: A total of 24 male Wistar albino rats were divided into 4 groups including 6 rats per group in this study. Groups are as follows; Control, Cisplatin (Cis) (8 mg/kg), Rapamycin (Rapa) (2 mg/kg), 3-methyladenine (3-MA) (15 mg/kg). Rapa and 3-MA were given intraperitoneally for 15 days. Cis was administered as a single dose on the 7th day of the experimental period. At the end of the experimental procedure, epididymis tissues were extracted. Hematoxylin and eosin staining and Heat shock protein-70 (HSP70) immunohistochemistry were applied to the sections taken after histological techniques. Results: Dispersion in the tubule basement membrane and vacuolization in the tubule was observed in the Cis group. It was also observed that some epithelial cells were more eosinophilic in the Cis group. Tissue sections of Rapa and 3-MA had a more regular appearance in terms of epithelization and tubule basement membrane. HSP70 immunoreactivity was observed in the intertubuler connective tissue of all groups. Conclusion: The epididymis was affected by agents such as Cis in terms of the protection of semen quality and potency of spermatozoa. Rapa may be more effective than 3-MA in the epididymis against Cis toxicity.
- 30 September 2021
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 46 (3) , 1184-1190
Open AccessHistological evaluation of the effects of rapamycin and 3-methyladenine on cisplatin-induced epididymal injury in rats
Purpose: In this study, we aimed to determine the effects of autophagy inhibitor and activator on Cisplatin (Cis)-induced tissue damage. Materials and Methods: A total of 24 male Wistar albino rats were divided into 4 groups including 6 rats per group in this study. Groups are as follows; Control, Cisplatin (Cis) (8 mg/kg), Rapamycin (Rapa) (2 mg/kg), 3-methyladenine (3-MA) (15 mg/kg). Rapa and 3-MA were given intraperitoneally for 15 days. Cis was administered as a single dose on the 7th day of the experimental period. At the end of the experimental procedure, epididymis tissues were extracted. Hematoxylin and eosin staining and Heat shock protein-70 (HSP70) immunohistochemistry were applied to the sections taken after histological techniques. Results: Dispersion in the tubule basement membrane and vacuolization in the tubule was observed in the Cis group. It was also observed that some epithelial cells were more eosinophilic in the Cis group. Tissue sections of Rapa and 3-MA had a more regular appearance in terms of epithelization and tubule basement membrane. HSP70 immunoreactivity was observed in the intertubuler connective tissue of all groups. Conclusion: The epididymis was affected by agents such as Cis in terms of the protection of semen quality and potency of spermatozoa. Rapa may be more effective than 3-MA in the epididymis against Cis toxicity.
- 8 September 2021
- Published by Wiley in Anatomia, Histologia, Embryologia
- Vol. 50 (6) , 908-917
Therapeutic effects of thymoquinone in doxorubicin‐induced hepatotoxicity via oxidative stress, inflammation and apoptosis
Cancer is a lethal disease that is characterized by uncontrolled cell division and proliferation, and it results in death in many organisms. Doxorubicin (DOX) is a therapeutic agent used for treatment of many cancer types, but it induces serious hepatotoxicity. In this study, we aimed to determine possible hepato‐therapeutic effects of thymoquinone (THQ) on DOX‐induced hepatotoxicity in rats. Rats were divided into five groups (n = 8): Control, THQ (10 mg/kg/day/i.p for 14 days), Olive Oil (equal volume with THQ for 14 days), DOX (single dose, 15 mg/kg/i.p on 7th day) and DOX + THQ (10 mg/kg/day/i.p and DOX 15 mg/kg/i.p on 7th day). At the end of the experiment, liver tissues were extracted and evaluated histopathologically. eNOS, iNOS and Cas‐3 immunostaining were performed to determine the expression levels. TUNEL method was used to determine apoptotic index. Furthermore, liver tissue total antioxidant status (TAS), total oxidant status (TOS), TNF‐α and TGF‐β levels were measured by ELISA assay. The DOX group showed histopathological deterioration compared to Control group. Moreover, apoptotic index, eNOS, iNOS and Cas‐3 expressions increased in DOX group. While TAS level of the DOX group decreased, TOS level increased. TNF‐α and TGF‐β levels increased in DOX group. However, there was improvement in DOX + THQ group compared to DOX group. Moreover, apoptotic cell number, eNOS, iNOS and Cas‐3 expressions decreased in DOX + THQ group compared to DOX group. We concluded that thymoquinone can be used as a phytotherapeutic for reducing DOX‐induced liver damage.
- 8 September 2021
- Published by Wiley in Anatomia, Histologia, Embryologia
- Vol. 50 (6) , 908-917
Therapeutic effects of thymoquinone in doxorubicin‐induced hepatotoxicity via oxidative stress, inflammation and apoptosis
Cancer is a lethal disease that is characterized by uncontrolled cell division and proliferation, and it results in death in many organisms. Doxorubicin (DOX) is a therapeutic agent used for treatment of many cancer types, but it induces serious hepatotoxicity. In this study, we aimed to determine possible hepato‐therapeutic effects of thymoquinone (THQ) on DOX‐induced hepatotoxicity in rats. Rats were divided into five groups (n = 8): Control, THQ (10 mg/kg/day/i.p for 14 days), Olive Oil (equal volume with THQ for 14 days), DOX (single dose, 15 mg/kg/i.p on 7th day) and DOX + THQ (10 mg/kg/day/i.p and DOX 15 mg/kg/i.p on 7th day). At the end of the experiment, liver tissues were extracted and evaluated histopathologically. eNOS, iNOS and Cas‐3 immunostaining were performed to determine the expression levels. TUNEL method was used to determine apoptotic index. Furthermore, liver tissue total antioxidant status (TAS), total oxidant status (TOS), TNF‐α and TGF‐β levels were measured by ELISA assay. The DOX group showed histopathological deterioration compared to Control group. Moreover, apoptotic index, eNOS, iNOS and Cas‐3 expressions increased in DOX group. While TAS level of the DOX group decreased, TOS level increased. TNF‐α and TGF‐β levels increased in DOX group. However, there was improvement in DOX + THQ group compared to DOX group. Moreover, apoptotic cell number, eNOS, iNOS and Cas‐3 expressions decreased in DOX + THQ group compared to DOX group. We concluded that thymoquinone can be used as a phytotherapeutic for reducing DOX‐induced liver damage.
- 15 August 2021
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (11) , e22888
Thymoquinone has a neuroprotective effect against inflammation, oxidative stress, and endoplasmic reticulum stress in the brain cortex, medulla, and hippocampus due to doxorubicin
Although doxorubicin (DOX) is used in many cancer treatments, it causes neurotoxicity. In this study, the effect of thymoquinone (THQ), a powerful antioxidant, on DOX‐induced neurotoxicity was evaluated. In total, 40 rats were used and 5 groups were formed. Group I: control group (n = 8); Group II: olive oil group (n = 8); Group III: the THQ group (n = 8); THQ 10 mg/kg per day was given intraperitoneally (i.p.) throughout the experiment; group IV: DOX group (n = 8); On Day 7 of the experiment, a single dose of 15 mg/kg intraperitoneally DOX injected; group V: DOX + THQ group (n = 8); Throughout the experiment, 10 mg/kg THQ per day and intraperitoneally 15 mg/kg DOX on Day 7 were injected. Immunohistochemically, tumor necrosis factor‐α (TNF‐α), interleukin‐17 (IL‐17), hypoxia‐inducible factor 1α (HIF1‐α), glucose regulatory protein 78 (GRP78), and the gene inducible by growth arrest and DNA damage 153 (GADD153) proteins were evaluated in the brain cortex, medulla, and hippocampus regions. Total oxidant status (TOS) levels and total antioxidant status (TAS) in the brain tissue were measured. TNF‐α, IL‐17, HIF1‐α, GRP78, and GADD153 immunoreactivities significantly increased in the DOX group in the study. THQ significantly reduced these values. THQ increased the TAS level significantly and decreased the TOS level significantly compared to the DOX group. THQ may play a role as a neuroprotective agent in DOX‐induced neurotoxicity in the cortex, medulla, and hippocampus regions of the brain.
- 15 August 2021
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (11) , e22888
Thymoquinone has a neuroprotective effect against inflammation, oxidative stress, and endoplasmic reticulum stress in the brain cortex, medulla, and hippocampus due to doxorubicin
Although doxorubicin (DOX) is used in many cancer treatments, it causes neurotoxicity. In this study, the effect of thymoquinone (THQ), a powerful antioxidant, on DOX‐induced neurotoxicity was evaluated. In total, 40 rats were used and 5 groups were formed. Group I: control group (n = 8); Group II: olive oil group (n = 8); Group III: the THQ group (n = 8); THQ 10 mg/kg per day was given intraperitoneally (i.p.) throughout the experiment; group IV: DOX group (n = 8); On Day 7 of the experiment, a single dose of 15 mg/kg intraperitoneally DOX injected; group V: DOX + THQ group (n = 8); Throughout the experiment, 10 mg/kg THQ per day and intraperitoneally 15 mg/kg DOX on Day 7 were injected. Immunohistochemically, tumor necrosis factor‐α (TNF‐α), interleukin‐17 (IL‐17), hypoxia‐inducible factor 1α (HIF1‐α), glucose regulatory protein 78 (GRP78), and the gene inducible by growth arrest and DNA damage 153 (GADD153) proteins were evaluated in the brain cortex, medulla, and hippocampus regions. Total oxidant status (TOS) levels and total antioxidant status (TAS) in the brain tissue were measured. TNF‐α, IL‐17, HIF1‐α, GRP78, and GADD153 immunoreactivities significantly increased in the DOX group in the study. THQ significantly reduced these values. THQ increased the TAS level significantly and decreased the TOS level significantly compared to the DOX group. THQ may play a role as a neuroprotective agent in DOX‐induced neurotoxicity in the cortex, medulla, and hippocampus regions of the brain.
- 29 August 2020
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (1) , e22618
Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats
Contrary to the fact that doxorubicin is a powerful chemotherapeutic agent for the treatment of neoplastic diseases, cardiotoxicity is too important to be ignored. Thymoquinone serves as a powerful free radical scavenger. In the study, the effects of thymoquinone against doxorubicin‐cardiotoxicity will be evaluated. Forty rats were divided into five groups. Group I: control group (n = 8); group II: olive oil group (n = 8); group III: thymoquinone group (n = 8); given 10 mg/kg thymoquinone intraperitoneally per day throughout the experiment; group IV: doxorubicin group (n = 8); injected with a single dose of 15 mg/kg ip doxorubicin on the 7th day of the experiment; group V: doxorubicin + thymoquinone group (n = 8); administered with 10 mg/kg thymoquinone per day during the experiment and 15 mg/kg doxorubicin ip on the 7th day. The experiment was planned for 14 days. Immunohistochemically, heat shock protein (HSP) 70 and HSP90, glucose‐regulated protein 78 (GRP78), caspase‐3 were stained. We made terminal deoxynucleotidyl transferase dUTP nick end labeling for apoptotic evaluation. Total oxidant status (TOS) levels and total antioxidant status (TAS) were measured in the heart tissue. Atrial natriuretic peptide (ANP) and pro‐B type natriuretic peptide (proBNP) were evaluated. In the study, HSP70, HSP90, GRP78, and caspase‐3 levels increased in group IV. TOS and TAS levels were significant compared to group I. Doxorubicin significantly increased ANP and NT‐proBNP levels. Thymoquinone revealed significant differences in these values. Thymoquinone can be an important cardioprotective agent against doxorubicin‐cardiotoxicity.
- 29 August 2020
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (1) , e22618
Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats
Contrary to the fact that doxorubicin is a powerful chemotherapeutic agent for the treatment of neoplastic diseases, cardiotoxicity is too important to be ignored. Thymoquinone serves as a powerful free radical scavenger. In the study, the effects of thymoquinone against doxorubicin‐cardiotoxicity will be evaluated. Forty rats were divided into five groups. Group I: control group (n = 8); group II: olive oil group (n = 8); group III: thymoquinone group (n = 8); given 10 mg/kg thymoquinone intraperitoneally per day throughout the experiment; group IV: doxorubicin group (n = 8); injected with a single dose of 15 mg/kg ip doxorubicin on the 7th day of the experiment; group V: doxorubicin + thymoquinone group (n = 8); administered with 10 mg/kg thymoquinone per day during the experiment and 15 mg/kg doxorubicin ip on the 7th day. The experiment was planned for 14 days. Immunohistochemically, heat shock protein (HSP) 70 and HSP90, glucose‐regulated protein 78 (GRP78), caspase‐3 were stained. We made terminal deoxynucleotidyl transferase dUTP nick end labeling for apoptotic evaluation. Total oxidant status (TOS) levels and total antioxidant status (TAS) were measured in the heart tissue. Atrial natriuretic peptide (ANP) and pro‐B type natriuretic peptide (proBNP) were evaluated. In the study, HSP70, HSP90, GRP78, and caspase‐3 levels increased in group IV. TOS and TAS levels were significant compared to group I. Doxorubicin significantly increased ANP and NT‐proBNP levels. Thymoquinone revealed significant differences in these values. Thymoquinone can be an important cardioprotective agent against doxorubicin‐cardiotoxicity.